Showing 581-590 of 682 results for "".
- Alphyn Biologics' Topical Performs Well in ADhttps://practicaldermatology.com/news/alphyn-biologics-topical-performs-well-in-ad/2461481/Alphyn B
- New GEM-3 Phase 3 Results for B-VEC Presented at 2022 AAD Annual Meetinghttps://practicaldermatology.com/news/new-gem-3-phase-3-results-for-b-vec-presented-at-2022-aad-annual-meeting/2461136/Krystal Biotech, Inc
- Colorescience Adds to Board of Directorshttps://practicaldermatology.com/news/colorescience-adds-to-board-of-directors/2457838/David Olsen and Ty Stiklorius are joining Colorescience’s Board of Directors. David Olsen is the Chief Executive Officer (CEO) of Cos Bar. Since joining Cos Bar in February 2016, he has worked to grow the company while
- ASA Honors Researchers At Annual Meeting of the Society for Investigative Dermatologyhttps://practicaldermatology.com/news/asa-honors-researchers-at-annual-meeting-of-the-society-for-investigative-dermatology/2458208/Richard Edelson, MD Chair and Professor, Department of Dermatology, Yale School of Medicine, took home the David Martin Carter Mentor Award from the American Skin Association at the Annual Meeting of the
- New App Connects Patients and Dermatologistshttps://practicaldermatology.com/news/new-app-connects-patients-and-dermatologists/2458594/The new Dermio app, developed by dermatologist David Soleymani, MD, allows users to confidentially send pictures and videos of rashes, acne and other skin conditions to be diagnosed by a dermatologist in 24 hours or less, according to a recent
- Cosmetic Bootcamp Adds Topics to Summer Meetinghttps://practicaldermatology.com/news/20120627-cosmetic_bootcamp_adds_topics_to_summer_meeting/2459778/The Cosmetic Bootcamp, an educational symposium for the core aesthetic specialties, has added topics to its summer sessions. These include Dr. David Sarwer (University of Pennsylvania, a nationally known expert on the psychology of cosmetic pati
- With New Funding, Turn Therapeutics Will Launch Phase 4 Study of AD Drughttps://practicaldermatology.com/news/with-new-funding-turn-therapeutics-will-launch-phase-4-study-of-ad-drug/2460162/Turn Therapeutics has closed its fully-subscribed series B financing. The capital raised will fund a large-scale, pre-launch, phase 4 trial for AtopX Eczema Emulsion, with enrollment scheduled to begin in Q1 2020. The series B financing will also support advancement of additional i
- Promising Pipeline for CSU Optionshttps://practicaldermatology.com/news/promising-pipeline-csu-options/2468488/Cleveland Clinic allergist Dr. David Lang joined Dr. Dawn Merritt and Dr. Brad P. Glick to discuss chronic spontaneous urticaria (CSU) at the 44th Annual Fall Clinical Dermatology Conference and noted that the future is very promising. “Our recent understanding of chronic urticaria has imp
- Cutera CEO, Executive Chairman Axedhttps://practicaldermatology.com/news/shake-up-at-cutera-shareholder-ceo-look-to-reconstitute-board/2461654/Cutera, Inc. has fired CEO David Mowry and Executive Chairman Daniel Plants for alleged violations of their employment contracts. Sheila Hopkins has been appointed as interim CEO and the search for a permanent replacement is underway. Plants and Mowry called for a Sp
- Dr. James G. Krueger Joins ASA’s Board of Directorshttps://practicaldermatology.com/news/dr-james-g-krueger-joins-asas-board-of-directors/2461651/James G. Krueger, MD, PhD, will join the American Skin Association’s (ASA) Board of Directors. Dr. Krueger is the David Martin Carter Professor in Clinical Investigation and Head of the Laboratory for Investigative Dermatology at The Rockefeller University in&